We have rapidly evolved into a fully integrated Indian pharmaceutical Company with its presence in all Four clusters of APIs, CRAMS, Generics, and NCEs (New Chemical Entities.Leveraging our world-class R&D base, we have taken up Contract Research and Manufacturing Services (CRAMS) as a discrete initiative and advanced, especially in the areas related to new Products and NCEs.

ANWITA flexible to work client -comfort models of Business to undertake a wide range of projects on a ‘FTE’ or ‘fee for service’ basis.

ANWITA offers comprehensive outsourcing options in registered starting materials,intermediates and APIs along with stability study activities. IP will be granted to customers depending on the type of business agreement entered into at the time of awarding a specific project.

Our portfolio includes many specialized R&D capabilities, with particular expertise in customized APIs, Intermediates, starting raw materials and stability study. We also offer solutions to manage the complete product lifecycle including extensions and regulatory support.

Our Services models:

  • API and customs synthesis
  • Development of Drug Master Files (DMFs)
  • NCE – Route of synthesis studies
  • NCE- Analytical Development
  • Stability studies as per all ICH Zones
  • Process development and technology transfer
  • Analytical Development and validations